- Home
- ALHC vs VERA Comparison
ALHC vs VERA Comparison
Compare ALHC & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALHC | VERA |
|---|---|---|
| Founded | 2013 | 2016 |
| Country | United States | United States |
| Employees | 1849 | N/A |
| Industry | Medical Specialities | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 3.0B |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ALHC | VERA |
|---|---|---|
| Price | $7.78 | $31.06 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 14 |
| Target Price | $22.23 | ★ $77.50 |
| AVG Volume (30 Days) | ★ 10.0M | 2.0M |
| Earning Date | 10-29-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 100.00 | N/A |
| EPS | ★ 0.22 | N/A |
| Revenue | ★ $3,948,719,000.00 | N/A |
| Revenue This Year | $32.06 | N/A |
| Revenue Next Year | $24.53 | $792.38 |
| P/E Ratio | $35.55 | ★ N/A |
| Revenue Growth | ★ 46.06 | N/A |
| 52 Week Low | $7.37 | $23.05 |
| 52 Week High | $25.12 | $56.05 |
Technical Indicators
Market Signals| Indicator | ALHC | VERA |
|---|---|---|
| Relative Strength Index (RSI) | 25.38 | 44.33 |
| Support Level | $7.37 | $30.05 |
| Resistance Level | $22.80 | $33.09 |
| Average True Range (ATR) | 0.76 | 2.06 |
| MACD | 0.02 | -0.22 |
| Stochastic Oscillator | 11.99 | 18.49 |
Price Performance
Historical ComparisonAbout ALHC Alignment Healthcare Inc.
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.